Target Name: EFCAB7
NCBI ID: G84455
Review Report on EFCAB7 Target / Biomarker Content of Review Report on EFCAB7 Target / Biomarker
EFCAB7
Other Name(s): EF-hand calcium binding domain 7 | RP4-534K7.1 | DKFZp666D225 | KIAA1799 | EFCB7_HUMAN | EF-hand calcium-binding domain-containing protein 7

Understanding The EF-CBD: A Potential Drug Target

The EF-hand calcium binding domain (EF-CBD) is a protein that is found in a variety of organisms, including humans. It is a key component of the protein EF-hand, which is a protein that is involved in the regulation of muscle contractions. The EF-CBD is a short protein that is composed of 21 amino acids.

One of the functions of the EF-CBD is to bind to calcium ions in the muscle. This interaction between the EF-CBD and calcium ions is important for the regulation of muscle contractions. When muscle is stimulated, the EF-CBD helps to facilitate the rapid contraction of the muscle fibers.

In addition to its role in muscle contractions, the EF-CBD is also involved in the regulation of other cellular processes. For example, it has been shown to play a role in the regulation of cell division, and it has been shown to interact with various signaling pathways.

Despite its importance, the EF-CBD is not well understood. There are only a few studies that have been conducted to investigate its function, and more research is needed to fully understand its role in the regulation of muscle contractions and other cellular processes.

One potential drug target for the EF-CBD is the use of small molecules that can modulate its activity. For example, researchers have developed a number of small molecules that have been shown to interact with the EF-CBD and to modulate its function. These small molecules include such things as rapamycin, a drug that is used to prevent the growth of cancer cells, and valproic acid, a drug that is used to treat certain mental disorders.

Another potential drug target for the EF-CBD is the use of antibodies that can target the protein and modulate its activity. Researchers have developed antibodies that are specific for the EF-CBD and that can bind to the protein and modulate its function. These antibodies have the potential to be used as a diagnostic tool and as a therapeutic agent.

In conclusion, the EF-hand calcium binding domain (EF-CBD) is a protein that is involved in the regulation of muscle contractions and other cellular processes. It is not well understood, and there is a need for more research to fully understand its function. The use of small molecules and antibodies as drug targets may provide new ways to modulate its activity and to investigate its role in the regulation of muscle contractions and other cellular processes.

Protein Name: EF-hand Calcium Binding Domain 7

Functions: Component of the EvC complex that positively regulates ciliary Hedgehog (Hh) signaling. Required for the localization of the EVC2:EVC subcomplex at the base of primary cilia

The "EFCAB7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EFCAB7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

EFCAB8 | EFCAB9 | EFCC1 | EFEMP1 | EFEMP2 | EFHB | EFHC1 | EFHC2 | EFHD1 | EFHD2 | EFL1 | EFL1P1 | EFNA1 | EFNA2 | EFNA3 | EFNA4 | EFNA5 | EFNB1 | EFNB2 | EFNB3 | EFR3A | EFR3B | EFS | EFTUD2 | EGF | EGFEM1P | EGFL6 | EGFL7 | EGFL8 | EGFLAM | EGFR | EGFR-AS1 | EGLN1 | EGLN2 | EGLN3 | EGOT | EGR1 | EGR2 | EGR3 | EGR4 | EHBP1 | EHBP1-AS1 | EHBP1L1 | EHD1 | EHD2 | EHD3 | EHD4 | EHF | EHHADH | EHMT1 | EHMT1 intronic transcript 1 | EHMT2 | EI24 | EI24P2 | EID1 | EID2 | EID2B | EID3 | EIF1 | EIF1AD | EIF1AX | EIF1AX-AS1 | EIF1AXP1 | EIF1AY | EIF1B | EIF1B-AS1 | EIF1P3 | EIF2 complex | EIF2A | EIF2AK1 | EIF2AK2 | EIF2AK3 | EIF2AK3-DT | EIF2AK4 | EIF2B1 | EIF2B2 | EIF2B3 | EIF2B4 | EIF2B5 | EIF2D | EIF2S1 | EIF2S2 | EIF2S2P3 | EIF2S2P4 | EIF2S3 | EIF3A | EIF3B | EIF3C | EIF3CL | EIF3D | EIF3E | EIF3EP1 | EIF3EP2 | EIF3F | EIF3FP2 | EIF3FP3 | EIF3G | EIF3H | EIF3I | EIF3IP1